Clinical

Dataset Information

The pharmacogenomics of antitumor efficacy of a bispecific antibody CD3×EpCAM that activates PBMC in colorectal cancer


ABSTRACT: Interventions: Healthy subject:collecting 15ml peripheral blood; colorectal cancer patient:collecting 5ml peripheral blood Primary outcome(s): cell apoptosis;cytokines levels;genotype Study Design: Case-Control study

DISEASE(S): Colorectal Cancer

PROVIDER: 2671701 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR